23 batches of drugs are not in conformity with the regulations, Nanjing Bai Jingyu, Shanxi Zhendong Taisheng roll call notice
-
Last Update: 2019-05-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On May 10, the State Food and Drug Administration announced the notice of the 23rd batch of drugs not conforming to the regulations The notice pointed out that the 23rd batch of drugs marked as produced by 8 enterprises such as Nanjing Baijingyu Pharmaceutical Co., Ltd did not conform to the regulations after being inspected by 4 drug inspection institutions such as Jiangxi Institute of drug inspection and testing The figure shows the specific publicity documents The figure below shows the specific drug companies and drug names This article is the content reprinted by yaozhi.com, and the copyright belongs to the original author The purpose of reprinting is to transmit more information, which does not represent the view of this platform If the content, copyright and other issues of the work are involved, please contact the message on this website, and we will delete the content as soon as possible
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
